Milestone Pharmaceuticals...
(MIST)
undefined
undefined%
At close: undefined
1.78
-0.81%
After-hours Dec 13, 2024, 07:58 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -59.69M | -58.39M | -42.85M | -49.97M | -55.23M | -23.18M | -8.09M |
| Depreciation & Amortization | 92.00K | 89.00K | 93.00K | 97.00K | 38.00K | 10.00K | 8.00K |
| Stock-Based Compensation | 9.53M | 9.05M | 7.28M | 4.95M | 1.19M | 633.00K | 190.00K |
| Other Working Capital | 207.00K | -2.35M | 1.62M | -3.72M | -672.00K | -1.38M | 58.00K |
| Other Non-Cash Items | 2.39M | 44.00K | 7.27M | 5.53M | 1.63M | 787.00K | 59.00K |
| Deferred Income Tax | - | - | -7.27M | -5.53M | -1.63M | - | - |
| Change in Working Capital | 1.24M | -3.26M | 2.26M | -5.81M | 2.85M | 1.50M | -164.00K |
| Operating Cash Flow | -46.42M | -52.47M | -33.22M | -50.73M | -51.15M | -21.05M | -8.05M |
| Capital Expenditures | -112.00K | -272.00K | - | - | -413.00K | -5.00K | -36.00K |
| Acquisitions | - | 86.12M | - | - | 35.41M | - | - |
| Purchase of Investments | -137.13M | -85.85M | -15.00M | -90.00M | -35.00M | -3.03M | -16.03M |
| Sales Maturities Of Investments | 142.00M | 29.00M | 85.00M | 20.00M | 35.03M | 19.03M | 45.00K |
| Other Investing Acitivies | - | -86.12M | 70.00M | -70.00M | -35.41M | 16.00M | -15.99M |
| Investing Cash Flow | 4.76M | -57.12M | 70.00M | -70.00M | -384.00K | 16.00M | -16.02M |
| Debt Repayment | 50.00M | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | -2.21M | 458.00K | 5.05M | 48.31M | 44.00K | 80.11M | 30.72M |
| Financial Cash Flow | 47.79M | 3.09M | 5.05M | 73.22M | 85.41M | 80.11M | 30.72M |
| Net Cash Flow | 6.12M | -106.50M | 41.83M | -47.51M | 33.87M | 75.07M | 6.65M |
| Free Cash Flow | -46.54M | -52.74M | -33.22M | -50.73M | -51.56M | -21.05M | -8.09M |